GB201805189D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB201805189D0
GB201805189D0 GBGB1805189.6A GB201805189A GB201805189D0 GB 201805189 D0 GB201805189 D0 GB 201805189D0 GB 201805189 A GB201805189 A GB 201805189A GB 201805189 D0 GB201805189 D0 GB 201805189D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1805189.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1805189.6A priority Critical patent/GB201805189D0/en
Priority to KR1020197032525A priority patent/KR20190137847A/en
Priority to JP2019556813A priority patent/JP7402691B2/en
Priority to EP18719542.5A priority patent/EP3612236A1/en
Priority to MX2019012465A priority patent/MX2019012465A/en
Priority to BR112019021680-4A priority patent/BR112019021680A2/en
Priority to AU2018253950A priority patent/AU2018253950A1/en
Priority to US16/605,708 priority patent/US11596696B2/en
Priority to CA3057744A priority patent/CA3057744A1/en
Priority to CN201880029617.2A priority patent/CN110582303A/en
Priority to EA202092515A priority patent/EA202092515A1/en
Priority to PCT/EP2018/060214 priority patent/WO2018193104A1/en
Publication of GB201805189D0 publication Critical patent/GB201805189D0/en
Ceased legal-status Critical Current

Links

GBGB1805189.6A 2017-04-20 2018-03-29 Combination therapy Ceased GB201805189D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1805189.6A GB201805189D0 (en) 2018-03-29 2018-03-29 Combination therapy
KR1020197032525A KR20190137847A (en) 2017-04-20 2018-04-20 Combination Therapy with Anti-CD25 Antibody-Drug Conjugates
JP2019556813A JP7402691B2 (en) 2017-04-20 2018-04-20 Combination therapy with anti-CD25 antibody drug conjugate
EP18719542.5A EP3612236A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate
MX2019012465A MX2019012465A (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate.
BR112019021680-4A BR112019021680A2 (en) 2017-04-20 2018-04-20 COMBINATION THERAPY WITH ANTI-CD25 ANTIBODY-DRUG CONJUGATE ??
AU2018253950A AU2018253950A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-CD25 antibody-drug conjugate
US16/605,708 US11596696B2 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-CD25 antibody-drug conjugate
CA3057744A CA3057744A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate
CN201880029617.2A CN110582303A (en) 2017-04-20 2018-04-20 Combination therapy with anti-CD 25 antibody-drug conjugates
EA202092515A EA202092515A1 (en) 2018-03-29 2018-04-20 COMBINATION THERAPY WITH ANTI-CD25 ANTI-BODY-DRUG CONJUGATE
PCT/EP2018/060214 WO2018193104A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1805189.6A GB201805189D0 (en) 2018-03-29 2018-03-29 Combination therapy

Publications (1)

Publication Number Publication Date
GB201805189D0 true GB201805189D0 (en) 2018-05-16

Family

ID=62142096

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1805189.6A Ceased GB201805189D0 (en) 2017-04-20 2018-03-29 Combination therapy

Country Status (2)

Country Link
EA (1) EA202092515A1 (en)
GB (1) GB201805189D0 (en)

Also Published As

Publication number Publication date
EA202092515A1 (en) 2021-06-21

Similar Documents

Publication Publication Date Title
IL277336A (en) Combination therapy
GB201804255D0 (en) Macrophage-based therapy
GB201819853D0 (en) Therapy
IL280968A (en) Combination therapy
IL279908A (en) Combination therapy
IL288237A (en) Combination therapy
IL280729A (en) Combination therapy
GB201906864D0 (en) Combination therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201815579D0 (en) Combination therapy
GB201814207D0 (en) Combination Therapy
ZA202200731B (en) Combination therapy
GB201820895D0 (en) Therapy
GB201805660D0 (en) Combination Therapy
GB201805189D0 (en) Combination therapy
GB201817385D0 (en) Therapy
GB201802947D0 (en) Combination therapy
GB201814038D0 (en) Ilven therapy
GB201919301D0 (en) Combination therapy
GB201917254D0 (en) Combination therapy
GB201914006D0 (en) Combination Therapy
GB201910473D0 (en) Combination therapy
GB201908227D0 (en) Combination therapy
GB201908233D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)